InvestorsHub Logo
Followers 25
Posts 2345
Boards Moderated 0
Alias Born 06/20/2020

Re: A deleted message

Tuesday, 03/30/2021 4:11:41 PM

Tuesday, March 30, 2021 4:11:41 PM

Post# of 233221

a drug that was gonna "blow the doors off" their trial then ended up a subset of a subset


HGEN's trial met its primary endpoint. It had 54% efficacy with the entire trial. Leronlimab had 24% efficacy with a subgroup that represented 16% of the trial.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News